Robert Drysdale Denied a License to Fight at UFC 167 Due To Elevated Testosterone Levels
It seems that Robert Drysdale’s much-anticipated UFC debut will again have to wait.
The former jiu-jitsu world champion Drysdale was set to fight Cody Donovan on the Nov. 16 UFC 167 card, but the Nevada State Athletic Commission has denied him a license to fight. Drysdale took an out-of-competition drug test, and was flagged for an elevated testosterone to epitestosterone ratio of 19.4 to 1, over three times the NSAC’s limit of 6 to 1. He was also tested for a variety of steroids, but results came back negative.
NSAC Executive Director Keith Kizer confirmed the abnormal test today, but said that as of yet, Drysdale has not been fined or suspended.
Drysdale and the UFC have not yet commented on the test.
Drysdale originally applied for a therapeutic use exemption (TUE) for testosterone replacement therapy (TRT) prior to his original UFC debut against Ednaldo Oliveira, which was supposed to have taken place at UFC 163, but the application was denied. Drysdale ended up pulling out of the fight due to a staph infection.
On his application prior to UFC 163, dated July 8, he stated that it was his first TUE request, and that he was not using banned substances, nor had he had any failed tests in the past. Included in his application was a letter from Las Vegas based anti-aging clinic TrimBody M.D., stating that Drysdale was currently being treated for hypogonadism with weekly testosterone injections.